Veracyte | VCYT - Le Chiffre D'Affaires De Vente





Ventes Changement Date
Agenus USD 33.7M 500K 2026-03
Agilent USD 1.84B 37M 2026-03
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 73.74M 190.29M 2026-03
Bruker USD 823.4M 153.8M 2026-03
Heron Therapeutics USD 40.59M 2.38M 2025-12
Illumina USD 1.09B 70M 2026-03
Intrexon USD 717K 511K 2024-06
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Laboratory Of America USD 3.54B 20M 2026-03
Ligand Pharmaceuticals USD 51.72M 7.94M 2026-03
Myriad Genetics USD 200.4M 9.4M 2026-03
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Siemens EUR 19.76B 620M 2026-03
Sonic Healthcare AUD 5.45B 470M 2025-12
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
Veracyte USD 139.07M 1.53M 2026-03
Waters USD 1.27B 338M 2026-03